secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxcyte, Inc. (PCVX)
CIK:        0001649094
Form:       8-K
Filed at:   2026-02-02T23:59:59+00:00
Accession:  0001193125-26-033578
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaxcyte raises $600.2M in public offering of 12.65M shares at $50/share
-----------------------------------------------------------------------

- Offering of 11M shares at $50.00 public price; underwriter option for 1.65M shares exercised.
- Net proceeds of approximately $600.2M after underwriting discounts and expenses.
- Underwriters purchased shares at $47.50 each; offering closed on February 2, 2026.
- Proceeds will support general corporate purposes, including pipeline development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649094/000119312526033578/0001193125-26-033578-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649094/000119312526033578/d54534d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-033578

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer